Pfizer Inc.
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 16.7B 14.7B 13.7B 17.8B
Cost of revenue 4.2B 3.8B 2.8B 5.9B
Gross profit 12.5B 10.9B 10.9B 11.9B
Operating expense
Research & development 3.9B 2.5B 2.2B 3.1B
Selling general and admin 3.2B 3.4B 3.0B 4.3B
Other operating expenses
Operating income 4.1B 3.8B 4.4B 3.1B
Non operating interest income
Income 138M 156M 143M 171M
Expense 652M 654M 654M 739M
Other income expense -289M -224M -1.1B -2.5B
Pretax income 3.3B 3.0B 2.8B -10M
Tax provision -216M 141M -189M -421M
Net income 3.6B 2.9B 3.0B 418M
Basic EPS 0.5 0.5 0.1
Diluted EPS 0.5 0.5 0.1
Basic average shares 5.7B 5.7B 5.7B
Diluted average shares 5.7B 5.7B 5.7B
EBITDA 6.2B 5.7B 6.5B 4.6B
Net income from continuing op. 3.6B 2.9B 3.0B 411M
Minority interests -9M -18M -6M -8M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 6 hours 57 minutes

02:32
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).